1. Vajen T, Koenen RR, Werner I, et al. Blocking CCL5-CXCL4 Heteromerization Preserves Heart Function After Myocardial Infarction By Attenuating Leukocyte Recruitment And Netosis. Sci Rep 2018; 8(1): 10647. 2. Virani SS, Nambi V, Hoogeveen R, et al. Relationship Between Circulating Levels Of RANTES (Regulated On Activation, Normal T-Cell Expressed, And Secreted) And Carotid Plaque Characteristics: The Atherosclerosis Risk In Communities (ARIC) Carotid MRI Study. Eur Heart J 2011; 32(4): 459-68. 3. Aukrust P, Halvorsen B, Yndestad A, et al. Chemokines And Cardiovascular Risk. Arterioscler Thromb Vasc Biol 2008; 28(11): 1909-19. 4. De Sutter J, Struyf S, Van De Veire NR, et al. Cardiovascular Determinants And Prognostic Significance Of CC Chemokine Ligand-18 (CCL18/PARC) In Patients With Stable Coronary Artery Disease. J Mol Cell Cardiol 2010; 49(5): 894-6. 5. Cabia B, Andrade S, Carreira MC, et al. A Role For Novel Adipose Tissue-Secreted Factors In Obesity-Related Carcinogenesis. Obes Rev 2016; 17(4): 361-76. 6. Wajchenberg BL. Subcutaneous And Visceral Adipose Tissue: Their Relation To The Metabolic Syndrome. Endocr Rev 2000; 21(6): 697-738. 7. Gesta S, Tseng YH, Kahn CR. Developmental Origin Of Fat: Tracking Obesity To Its Source. Cell 2007; 131(2): 242-56. 8. Wozniak SE, Gee LL, Wachtel MS, et al. Adipose Tissue: The New Endocrine Organ? A Review Article. Dig Dis Sci 2009; 54(9): 1847-56. 9. Scheja L, Heeren J. The Endocrine Function Of Adipose Tissues In Health And Cardiometabolic Disease. Nat Rev Endocrinol 2019; 15(9): 507-24. 10. Booth A, Magnuson A, Fouts J, et al. Adipose Tissue: An Endocrine Organ Playing A Role In Metabolic Regulation. Horm Mol Biol Clin Investig 2016; 26(1): 25-42. 11. Balistreri CR, Caruso C, Candore G. The Role Of Adipose Tissue And Adipokines In Obesity-Related Inflammatory Diseases. Mediators Inflamm 2010; 2010: 802078. 12. Juge-Aubry CE, Henrichot E, Meier CA. Adipose Tissue: A Regulator Of Inflammation. Best Pract Res Clin Endocrinol Metab 2005; 19(4): 547-66. 13. Pineiro R, Iglesias MJ, Gallego R, et al. Adiponectin Is Synthesized And Secreted By Human And Murine Cardiomyocytes. FEBS Lett 2005; 579(23): 5163-9. 14. Wang Y, Lau WB, Gao E, et al. Cardiomyocyte-Derived Adiponectin Is Biologically Active In Protecting Against Myocardial Ischemia-Reperfusion Injury. Am J Physiol Endocrinol Metab 2010; 298(3): e663-70. 15. Yamaguchi T, Kitamori K, Ichihara G, et al. Serial Changes In Adipocytokines And Cardiac Function In A Rat Model Of The Metabolic Syndrome. Clin Exp Pharmacol Physiol 2013; 40(7): 443-8. 16. Michalski B, Szymczyk E, Peczek L, et al. The Role Of Selected Adipokines And Ghrelin In The Prognosis After Myocardial Infarction In A 12-Month Follow-Up In The Presence Of Metabolic Syndrome. Arch Med Sci 2017; 13(4): 785-94. 17. Mancuso P. The Role Of Adipokines In Chronic Inflammation. Immunotargets Ther 2016; 5: 47-56. 18. Sull JW, Kim HJ, Yun JE, et al. Serum Adiponectin Is Associated With Smoking Status In Healthy Korean Men. Endocr J 2009; 56(1): 73-8. 19. Mancuso P, Huffnagle GB, Olszewski MA, et al. Leptin Corrects Host Defense Defects After Acute Starvation In Murine Pneumococcal Pneumonia. Am J Respir Crit Care Med 2006; 173(2): 212-8. 20. Kumada M, Kihara S, Sumitsuji S, et al. Association Of Hypoadiponectinemia With Coronary Artery Disease In Men. Arterioscler Thromb Vasc Biol 2003; 23(1): 85-9. 21. Izadi M, Zarifian A, Eghdami A, et al. Relationship between cardiovascular risk factors and blood adiponectin in diabetic males. Iran South Med J 2012; 15(2): 101-7. 22. Lau WB, Ohashi K, Wang Y, et al. Role Of Adipokines In Cardiovascular Disease. Circ J 2017; 81(7): 920-8. 23. Ntaios G, Gatselis NK, Makaritsis K, et al. Adipokines As Mediators Of Endothelial Function And Atherosclerosis. Atherosclerosis 2013; 227(2): 216-21. 24. Mocan Hognogi LD, Goidescu CM, Farcas AD. Usefulness Of The Adipokines As Biomarkers Of Ischemic Cardiac Dysfunction. Dis Markers 2018; 2018: 3406028. 25. Lai B, Wang J, Fagenson A, et al. Twenty Novel Disease Group-Specific And 12 New Shared Macrophage Pathways In Eight Groups Of 34 Diseases Including 24 Inflammatory Organ Diseases And 10 Types Of Tumors. Front Immunol 2019; 10: 2612. 26. Lubos E, Messow CM, Schnabel R, et al. Resistin, Acute Coronary Syndrome And Prognosis Results From The Atherogene Study. Atherosclerosis 2007; 193(1): 121-8. 27. Takeishi Y, Niizeki T, Arimoto T, et al. Serum Resistin Is Associated With High Risk In Patients With Congestive Heart Failure--A Novel Link Between Metabolic Signals And Heart Failure. Circ J 2007; 71(4): 460-4. 28. Grzywocz P, Mizia-Stec K, Wybraniec M, et al. Adipokines And Endothelial Dysfunction In Acute Myocardial Infarction And The Risk Of Recurrent Cardiovascular Events. J Cardiovasc Med (Hagerstown) 2015; 16(1): 37-44. 29. Sajedi Khanian M, Abdi Ardekani A, Khosropanah S, et al. Correlation Of Early And Late Ejection Fractions With CCL5 And CCL18 Levels In Acute Anterior Myocardial Infarction. Iran J Immunol 2016; 13(2): 100-13. 30. Jamaluddin MS, Weakley SM, Yao Q, et al. Resistin: Functional Roles And Therapeutic Considerations For Cardiovascular Disease. Br J Pharmacol 2012; 165(3): 622-32. 31. Savage DB, Sewter CP, Klenk ES, et al. Resistin / Fizz3 Expression In Relation To Obesity And Peroxisome Proliferator-Activated Receptor-Gamma Action In Humans. Diabetes 2001; 50(10): 2199-202. 32. Kuzmicki M, Telejko B, Szamatowicz J, et al. High Resistin And Interleukin-6 Levels Are Associated With Gestational Diabetes Mellitus. Gynecol Endocrinol 2009; 25(4): 258-63. 33. Oikonomou EK, Antoniades C. The Role Of Adipose Tissue In Cardiovascular Health And Disease. Nat Rev Cardiol 2019; 16(2): 83-99. 34. Landecho MF, Tuero C, Valenti V, et al. Relevance Of Leptin And Other Adipokines In Obesity-Associated Cardiovascular Risk. Nutrients 2019; 11(11): 2664. 35. Wang H, Chen DY, Cao J, et al. High Serum Resistin Level May Be An Indicator Of The Severity Of Coronary Disease In Acute Coronary Syndrome. Chin Med Sci J 2009; 24(3): 161-6. 36. Hu WL, Qiao SB, Hou Q, et al. Plasma Resistin Is Increased In Patients With Unstable Angina. Chin Med J 2007; 120(10): 871-5. 37. Park HK, Ahima RS. Resistin In Rodents And Humans. Diabetes Metab J 2013; 37(6): 404-14. 38. Reilly MP, Lehrke M, Wolfe ML, et al. Resistin Is An Inflammatory Marker Of Atherosclerosis In Humans. Circulation 2005; 111(7): 932-9. 39. Zhang Z, Xing X, Hensley G, et al. Resistin Induces Expression Of Proinflammatory Cytokines And Chemokines In Human Articular Chondrocytes Via Transcription And Messenger RNA Stabilization. Arthritis Rheum 2010; 62(7): 1993-2003. 40. Park HK, Kwak MK, Kim HJ, et al. Linking Resistin, Inflammation, And Cardiometabolic Diseases. Korean J Intern Med 2017; 32(2): 239-47. 41. Huber J, Kiefer FW, Zeyda M, et al. CC Chemokine And CC Chemokine Receptor Profiles In Visceral And Subcutaneous Adipose Tissue Are Altered In Human Obesity. J Clin Endocrinol Metab 2008; 93(8): 3215-21. 42. Xu Y, Ma M, Ippolito GC, et al. Complement Activation In Factor D-Deficient Mice. Proc Natl Acad Sci U S A 2001; 98(25): 14577-82. 43. Wang JS, Lee WJ, Lee IT, et al. Association Between Serum Adipsin Levels And Insulin Resistance In Subjects With Various Degrees Of Glucose Intolerance. J Endocr Soc 2019; 3(2): 403-10. 44. Al-Daghri NM, Al-Ajlan AS, Alfawaz H, et al. Serum Cytokine, Chemokine And Hormone Levels In Saudi Adults With Pre-Diabetes: A One-Year Prospective Study. Int J Clin Exp Pathol 2015; 8(9): 11587-93. 45. Wang Y, Zheng X, Xie X, et al. Correlation Of Increased Serum Adipsin With Increased Cardiovascular Risks In Adult Patients With Growth Hormon Defficiency. Endocr Pract 2019; 25(5): 446-53.
|